Skip to main content
SpringerLink
Log in

Pharmacogenetic Problems of Antitumor Therapy (A Review)

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. P. Dean, P. Gane, and E. Zanders, in: Pharmacogenomics. The Search for Individualized Therapies, J. Licinio and M. Wong (eds.), Wiley-VCH Verlag GmbH, Weinheim, Germany (2002), pp. 143–157.

    Google Scholar 

  2. L. A. Piruzyan, Izv. Akad. Nauk SSSR, Ser. Biol., No. 2, 302–303 (1990).

    Google Scholar 

  3. L. A. Piruzyan, V. A. Sukhanov, and A. N. Saprin, Fiziol. Chel., 26(2), 115–123 (2000).

    Google Scholar 

  4. L. A. Piruzyan, V. A. Sukhanov, E. V. Kalinina, and A. N. Saprin, Dokl. Ross Akad. Nauk, 377(1), 129–131 (2001).

    Google Scholar 

  5. L. A. Piruzyan, V. A. Sukhanov, E. V. Kalinina, et al., Izv. Akad Ross. Nauk, Ser. Biol., No. 149–154 (2002).

  6. L. A. Piruzyan and E. M. Mikhailovskii, Fiziol. Chel., 27(3), 113–121 (2001).

    Google Scholar 

  7. L. A. Piruzyan and E. M. Mikhailovskii, Fiziol. Chel., 28(1), 101–115 (2002).

    Google Scholar 

  8. L. A. Piruzyan and E. M. Mikhailovskii, Fiziol. Chel., 28(5), 103–111 (2002).

    Google Scholar 

  9. L. A. Piruzyan and E. M. Mikhailovskii, Fiziol. Chel., 29(2), 118–126 (2003).

    Google Scholar 

  10. L. A. Piruzyan, L. A. Radkevich, and N. V. Morozova, Dokl. Ross Akad. Nauk, 388(6), 842–846 (2003).

    Google Scholar 

  11. A. N. Saprin, Usp. Biol Khim., 32, 146–175 (1991).

    Google Scholar 

  12. W. Kalow, Lancet, 268(8087), 211–256 (1956).

    Google Scholar 

  13. H. J. Dengler and M. Eichelbaum, Arzneimitt. Forsch., 27(96), 1836–1844 (1977).

    Google Scholar 

  14. L. Iyer and M. J. Ratain, Eur. J. Cancer, 34(10), 1493–1499 (1998).

    Google Scholar 

  15. F. Innocenti and M. J. Ratain, Eur. J. Cancer, 38(5), 639–644 (2002).

    Google Scholar 

  16. Pharmacogenomics, J. Lucinio and M. L. Wong, (eds.), Wiley-VCH Verlag GmBH, Weinheim, Germany (2002).

    Google Scholar 

  17. U. Peters, S. Preisler, A. Hebeisen, et al., Anticancer drugs, 11(8), 639–643 (2000).

    Google Scholar 

  18. R. Danesi, F. de Braud, S. Fogli, et al., Trends Pharmacol. Sci., 22(8), 420–426 (2001).

    Google Scholar 

  19. T. B. Felder, M. A. McLean, M. L. Vestal, et al., Drug. Metab. Dispos., 15(7), 773–777 (1987).

    Google Scholar 

  20. U. A. Meyer and U. M. Zanger, Ann. Rev. Pharmacol. Toxicol., 37(3), 269–296 (1997).

    Google Scholar 

  21. D. M. Grant, G. H. Goodfellow, K. Sugamori, et al., Pharmacology, 61(3), 204–211 (2000).

    Google Scholar 

  22. I. Cascorbi, N. Drakoulis, J. Brockmoller, et al., Am. J. Human Genet., 57(6), 581–592 (1995).

    Google Scholar 

  23. M. J Ratain, R. Mick, F. Berezin, et al., Clin. Pharmacol. Ther., 50(5), 573–579 (1991).

    Google Scholar 

  24. M. J. Ratein, G. Rosner, S. L. Allen, et al., J. Clinical. Oncol., 13(6), 741–747 (1995).

    Google Scholar 

  25. M. J. Ratain, R. Mick, F. Berezin, et al., Cancer Res., 53(8), 2304–2307 (1993).

    Google Scholar 

  26. M. J. Ratain, R. Mick, L. Janish, et al., Pharmacogenetics, 6(1), 93–101 (1996).

    Google Scholar 

  27. M. D. Mashkovskii, Drugs [in Russian], Meditsina, Moscow (1993), p. 520.

    Google Scholar 

  28. F. Stephan, M. C. Etienne, C. Wallays, et al., Am. J. Med., 99(5), 685–688 (1995).

    Google Scholar 

  29. J. Milano, M. C. Etienne, V. Pierrefite, et al., Br. J. Cancer, 799(5), 627–630 (1999).

    Google Scholar 

  30. R. A. Fleming, J. A. Milano, M. H. Gaspard, et al., Eur. J. Cancer, 29A(6), 740–744 (1993).

    Google Scholar 

  31. Z. Lu, R. Zhang, and R. B. Diasio, Cancer Res., 53(16), 5433–5438 (1993).

    Google Scholar 

  32. R. B. Diasio and M. R. Johnson, Pharmacology, 61(3), 199–203 (2000).

    Google Scholar 

  33. A. B. van Kuilenburg, J. Haasies, D. J. Richel, et al., Clin. Cancer Res., 6(14), 4705–4712 (2000).

    Google Scholar 

  34. R. Danesi, F. de Braud, S. Fogli, et al., Trends Pharmac. Sci., 22(3), 420–426 (2001).

    Google Scholar 

  35. L. P. Rivoli, J. F. Riou, M. C. Haaz, et al., Cancer Res., 56(12), 3689–3694 (1996).

    Google Scholar 

  36. Y. Kawato, T. Furuta, M. Aonuma, et al., Cancer Chemother. Pharmacol., 28(1), 192–198 (1991).

    Google Scholar 

  37. R. Humerickhouse, K. Lohrbach, L. Li, et al., Cancer Res., 60(4), 1189–1192 (2000).

    Google Scholar 

  38. L. P. Rivory, M. R. Bowles, J. Robert, et al., Biochem. Pharmacol., 52(8), 1103–1111 (1996).

    Google Scholar 

  39. E. Araki, M. Ishikawa, M. Iigo, et al., Jpn. J. Cancer Res., 84(4), 697–702 (1993).

    Google Scholar 

  40. G. Monaghan, M. Ryan, R. Seddon, et al., Lancet, 347(9026), 578–581 (1996).

    Google Scholar 

  41. E. Beutler, T. Gelbart, and A. Demina, Proc. Natl. Acad. Sci. USA, 95(20), 8170–8174 (1998).

    Google Scholar 

  42. G. Vonaghan, B. Foster, M. Jurima-Romet, et al., Pharmacogenetics, 7(1), 153–156 (1997).

    Google Scholar 

  43. D. Owens and L. Evans, J. Med. Genet., 12(1), 152–156 (1975).

    Google Scholar 

  44. Y. Ando, M. Chida, K. Nakayama, et al., Pharmacogenetics, 8(2), 357–360 (1998).

    Google Scholar 

  45. P. J. Bosma, J. R. Chowdhury, C. Bakker, et al., N. Engl. J. Med., 333(5), 1171–1175 (1995).

    Google Scholar 

  46. Y. Ando, H. Saka, M. Ando, et al., Cancer Res., 60(17), 6921–6926 (2000).

    Google Scholar 

  47. Y. H. Ling, J. H. Chan, K. Beattie, et al., Mol. Pharmacol., 42(4), 802–807 (1992).

    Google Scholar 

  48. M. Deininger, C. L. Szumlanski, D. M. Otterness, et al., Biochem. Pharmacol., 48(12), 2135–2138 (1994).

    Google Scholar 

  49. L. C. Woodson, M. M. Ames, C. D. Sellasie, et al., Mol. Pharmacol., 24(3), 471–478 (1993).

    Google Scholar 

  50. L. Lennard, Eur. J. Clin. Pharmacol., 43(2), 329–339 (1992).

    Google Scholar 

  51. S. Zimm, J. M. Collins, M. Riccardi, et al., N. Engl. J. Med., 308(10), 1005–1009 (1983).

    Google Scholar 

  52. L. Lennard, J. A. van Loon, and R. M. Weinshilboum, Clin. Pharmacol. Ther., 46(2), 149–154 (1989).

    Google Scholar 

  53. E. Y. Krynetski, H. L. Tai, C. R. Yates, et al., Pharmacogenetics, 6(2), 279–290 (1996).

    Google Scholar 

  54. W. E. Evans, M. Horner, J. Q. Chu, et al., J. Ped., 119(5), 985–989 (1991).

    Google Scholar 

  55. L. Lennard, J. S. Lilleyman, J. van Loon, et al., Lancet, 336(8738), 225–229 (1990).

    Google Scholar 

  56. R. M. Weinshilboum and S. L. Sladek, Am. J. Hum. Gen., 32(4), 651–652 (1980).

    Google Scholar 

  57. H. L. McLeod, J. S. Lin, E. P. Scott, et al., Clin. Pharmacol. Ther., 55(1), 15–20 (1994).

    Google Scholar 

  58. P. R. Chocair, J. A. Duley, E. Sabbaga, et al., Q. J. Med., 86(2), 359–363 (1993).

    Google Scholar 

  59. I. J. Jang, S. G. Shin, K. H. Lee, et al., Br. J. Clin. Pharmacol., 42(2), 638–641 (1996).

    Google Scholar 

  60. H. L. McLeod, E. Y. Krynetski, J. A. Wilimas, et al., Pharmacogenetics, 5(2), 281–286 (1995).

    Google Scholar 

  61. C. Szumlanski, R. Honchel, M. C. Scott, and R. M. Weinshilboum, Pharmacogenetics, 2(1), 148–159 (1992).

    Google Scholar 

  62. H. L. McLeod, M. V. Relling, Q. Liu, et al., Blood, 85(6), 1897–1902 (1995).

    Google Scholar 

  63. W. E. Evans, Y. Y. Hon, L. Bomgaars, et al., J. Clin. Oncol., 19(8), 2293–2301 (2001).

    Google Scholar 

  64. M. V. Relling, M, L. Hancock, G. K. Rivera, et al., J. Natl. Cancer Inst., 91(21), 2001–2008 (1999).

    Google Scholar 

  65. M. V. Relling, M. L. Hancock, J. M. Boyett, et al., Blood, 93(8), 2817–2823 (1999).

    Google Scholar 

  66. J. P. Vuchetich, R. M. Weinshilboum, and R. A. Price, Genet. Epidemiol., 12(1), 1–11 (1995).

    Google Scholar 

  67. E. Y. Krynetski, M. Y. Fessing, C. R. Yates, et al., Pharm. Res., 14(15), 1672–1678 (1997).

    Google Scholar 

  68. M. C. Spire-Vayron, H. Debuysere, B. Mastain, et al., Br. J. Pharmacol., 125(6), 879–887 (1997).

    Google Scholar 

  69. M. C. Spire-Vayron, H. Debuysere, F. Fasio, et al., Pharmacogenetics, 9(2), 189–198 (1999).

    Google Scholar 

  70. S. Alves, A. Amorim, F. Ferreira, et al., Clin. Pharmacol. Ther., 70(1), 165–174 (2001).

    Google Scholar 

  71. L. Yan, S. Zhang, B. Eiff, et al., Clin. Pharmacol. Therap., 68(2), 210–219 (2000).

    Google Scholar 

  72. T. Seki, T. Tanaka, and J. Nakamura, J. Hum. Genet., 45(6), 299–302 (2000).

    Google Scholar 

  73. M. V. Relling, R. Evans, C. Dass, et al., J. Pharmacol. Exp. Ther., 261(3), 491–496 (1992).

    Google Scholar 

  74. T. K. H. Chang, G. F. Weber, C. L. Crespi, et al., Cancer Res., 53(17), 5729–5737 (1993).

    Google Scholar 

  75. D. Walker, J. P. Flinois, S. C. Monkman, et al., Biochem. Pharmacol., 45(8), 1157–1163 (1994).

    Google Scholar 

  76. X. J. Zhou, X. R. Zhou-Pan, T. Gauthier, et al., Biochem. Pharmacol., 45(6), 853–861 (1993).

    Google Scholar 

  77. M. J. Wacher, W. Chi-Yuan, and L. Z. Benet, Mol. Carcinogen., 13(1), 129–134 (1995).

    Google Scholar 

  78. X. R. Zhou-Pan, E. Seree, X. J. Zhou, et al., Cancer Res., 53(15), 5121–5126 (1993).

    Google Scholar 

  79. J. W. Harris, A. Rahman, B. R. Kim, et al., Cancer Res., 54(13), 4026–4035 (1994).

    Google Scholar 

  80. I. Royer, B. Monsarrat, M. Sonnier, et al., Cancer Res., 56(1), 58–65 (1996).

    Google Scholar 

  81. G. I. Murray, Br. J. Cancer, 79(17), 1836–1842 (1999).

    Google Scholar 

  82. C. A. Felix, PNAS USA, 95(34), 13176–13181 (1998).

    Google Scholar 

  83. C. B. Ambrosone, C. Sweeney, B. F. Coles, et al., Cancer Res., 61(21), 7130–7135 (2001).

    Google Scholar 

  84. R. E. Howells, C. W. Redman, K. K. Dhar, et al., Clin. Cancer Res., 4(8), 2439–2445 (1998).

    Google Scholar 

  85. M. Stanulla, M. Schrappe, A. M. Brechlin, et al., Blood, 95(4), 1222–1228 (2000).

    Google Scholar 

  86. Genes and Cancer, J. E. Bishop, J. D. Rowley, and M. Greaves (eds.), Alan R. Liss, New York (1984).

    Google Scholar 

  87. J. German (ed.), Chromosome Mutation and Neoplasia, Alan R. Liss, New York (1983).

    Google Scholar 

  88. G. Klein and E. Klein, Cancer Res., 46(9), 3211–3224 (1986).

    Google Scholar 

  89. Biochemistry and Molecular Genetics of Cancer Metastasis, K. Lapis, L. A. Liotta, and A. S. Rabson (eds.), M. Nijhoff, The Hague (1986).

    Google Scholar 

  90. E. Mihich (ed.), Biological Responses in Cancer, Plenum Publishing Corp., New York (1985).

    Google Scholar 

  91. G. L. Nicolson, Cancer Res., 47(4), 1473–1487 (1987).

    Google Scholar 

  92. P. C. Nowell, Science, 194(1), 23–28 (1976).

    Google Scholar 

  93. P. C. Nowell, Cancer Res., 46(6), 2203–2207 (1986).

    Google Scholar 

  94. H. Rubin, Cancer Res., 45(8), 2935–2942 (1985).

    Google Scholar 

  95. Cancer Metastasis: Experimental and Clinical Strategies, D. R. Welch, B. K. Bhuyan, and L. A. Liotta (eds.), Alan R. Liss, New York (1986).

    Google Scholar 

  96. V. A. Sukhanov, Usp. Biol. Khim., 35, 97–134 (1995).

    Google Scholar 

  97. Y. S. Cho-Chung, Cancer Res., 50(20), 7093–7100 (1990).

    Google Scholar 

  98. N. Saijo, T. Tamura, N. Yamamoto, and K. Nishio, Cancer Chemother. Pharmacol., 48 (Suppl 1), S102–106 (2001).

    Google Scholar 

  99. A. A. Adjei, Curr. Pharm. Res., 6(3), 361–366 (2001).

    Google Scholar 

  100. W. Arap, R. Pasqualini, and E. Ruoslahti, Curr. Opin. Oncol., 10(4), 560–567 (1998).

    Google Scholar 

  101. G. Powis, Pharmacol. Ther., 62(1), 57–62 (1998).

    Google Scholar 

  102. A. Levitski, Pharmacol. Ther., 82(2), 231–235 (1999).

    Google Scholar 

  103. A. Levitski and A. Gazit, Science, 267(5116), 1782–1783 (1995).

    Google Scholar 

  104. K. Garber, J. Natl. Cancer Inst., 92(9), 967–970 (2000).

    Google Scholar 

  105. G. M. Marx, S. McCowatt, F. Boyle, et al., Proc. Am. Soc. Clin. Oncol., 19(3), A613–617 (2000).

    Google Scholar 

  106. L. E. Via, R. E. Gore-Langton, and J. M. Pluda, Oncology, 14(6), 1312–1316 (2000).

    Google Scholar 

  107. A. Stopeck, Proc. Am. Soc. Clin. Oncol., 19(5), A820–824 (2000).

    Google Scholar 

  108. A. D. Laird, P. Vajkoczy, L. K. Shawver, et al., Cancer Res., 60(11), 4152–4155 (2000).

    Google Scholar 

  109. F. Ciardiello, R. Caputo, R. Bianco, et al., Clin. Cancer Res., 6(5), 2053–2060 (2000).

    Google Scholar 

  110. M. Talpaz, C. L. Sawyer, H. Kantarjain, et al., Proc. Am. Soc. Clin. Oncol., 19(1), A6–9 (2000).

    Google Scholar 

  111. V. A. Sukhanov, L. F. Morozova, and V. L. D'yakov, Tsitologiya, 35(1), 101–104 (1993).

    Google Scholar 

  112. V. A. Sukhanov, L. F. Morozova, V. V. Lalaev, et al., Vopr. Med. Khim., 16(6), 73–77 (1991).

    Google Scholar 

  113. V. A. Sukhanov, V. L. D'yakov, V. V. Lalaev, and A. V. Yakh'yaev, Biokhimiya, 56(6), 1026–1035 (1991).

    Google Scholar 

  114. V. A. Sukhanov, I. M. Voronkova, S. V. Shvets, and L. F. Morozova, Biokhimiya, 58(2), 211–222 (1993).

    Google Scholar 

  115. S. V. Shvets, S. E. Severin, V. A. Sukhanov, Biomembrany, 7(8), 805–813 (1990)

    Google Scholar 

  116. V. A. Sukhanov, I. M. Voronkova, S. V. Shvets, et al., Biochem. Int., 24(5), 625–633 (1991).

    Google Scholar 

  117. V. A. Sukhanov, I. M. Voronkova, V. V. Lalaev, and L. F. Morozova, Eur. J. Endocrinol., 130(2), suppl.2, 158 (1994).

    Google Scholar 

  118. V. A. Sukhanov, V. L. Dyakov, V. V. Lalaev, and L. F. Morozova, VI Int. Congr. on Hormones and Cancer, Abstracts, Amsterdam, The Netherlands (1991), p. 415.

  119. V. A. Sukhanov, I. M. Voronkova, V. V. Lalaev, and L. F. Morozova, III Eur. Congr. of Endocrinology, Abstracts, Amsterdam, The Netherland, 2.068 (1994).

  120. V. A. Sukhanov, V. L. D'yakov, V. V. Lalaev, and L. F. Morozova, Biokhimiya, 61(4), 697–706 (1996).

    Google Scholar 

  121. A. V. Yakh'yaev, V. A. Sukhanov, V. K. Sologub, et al., Immunologiya, No. 4, 60–63 (1997).

    Google Scholar 

  122. T. A. Davis, C. A. White, A. J. Grillo-Lopez, et al., J. Clin. Oncol., 17(18), 1851–1858 (1999)

    Google Scholar 

  123. T. A. Davis, A. J. Grillo-Lopez, C. A. White, et al., J. Clin. Oncol., 18(30), 3135–3140 (2000).

    Google Scholar 

  124. D. J. Maloney, A. J. Grillo-Lopez, C. A. White, et al., Blood, 90(7), 2188–2194 (1997).

    Google Scholar 

  125. J. Baselga, D. Tripathy, J. Mendelsohn, et al., J. Clin. Oncol., 14(6), 737–743 (1996).

    Google Scholar 

  126. J. Baselga, D. Tripathy, J. Mendelsohn, et al., Semin. Oncol., 26(1), 78–81 (1999).

    Google Scholar 

  127. H. A. Burris, Semin. Oncol., 27(1), 19–21 (2000).

    Google Scholar 

  128. M. A. Cobleigh, C. L. Vogel, and D. J. Tripathy, Clin. Oncol., 17(25), 2639–2642 (2000).

    Google Scholar 

  129. M. D. Pegram, A. Lipton, D. F. Hayes, et al., J. Clin. Oncol., 16(24), 2659–2668 (1998).

    Google Scholar 

  130. S. Shak, Semin. Oncol., 26(1), 71–85 (1999).

    Google Scholar 

  131. J. Baselga, D. Pfister, M. R. Cooper, et al., J. Clin. Oncol., 18(8), 904–907 (2000).

    Google Scholar 

  132. R. A. Brekken, J. P. Overholser, V. A. Stastny, et al., Cancer Res., 60(13), 5117–5122 (2000).

    Google Scholar 

  133. J. M. Schlaeppi and J. M. Wood, Cancer Metastasis Rev., 18(3), 473–482 (1999).

    Google Scholar 

  134. K. A. Foon, J. Lutzky, R. N. Baral, et al., J. Clin. Oncol., 18(2), 376–382 (2000).

    Google Scholar 

  135. N. Hanai, K. Nakamura, and K. Shitara, Cancer Chemother. Pharmacol., 46(1), S13 (2000).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences, Moscow, Russia

    V. A. Sukhanov, A. N. Saprin & L. A. Piruzyan

Authors
  1. V. A. Sukhanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. N. Saprin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. A. Piruzyan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sukhanov, V.A., Saprin, A.N. & Piruzyan, L.A. Pharmacogenetic Problems of Antitumor Therapy (A Review). Pharmaceutical Chemistry Journal 38, 347–354 (2004). https://doi.org/10.1023/B:PHAC.0000048430.49990.0b

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:PHAC.0000048430.49990.0b

Keywords

Search

Navigation